z-logo
open-access-imgOpen Access
Cytisine versus Nicotine for Smoking Cessation
Author(s) -
Witold Zatoński,
Mateusz Zatoński
Publication year - 2015
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmc1500342
Subject(s) - cytisine , medicine , smoking cessation , nicotine , randomized controlled trial , novelty , the renaissance , nicotine dependence , cohort , traditional medicine , psychiatry , nicotinic agonist , psychology , social psychology , receptor , pathology , art , art history
To the Editor: Walker et al. (Dec. 18 issue)1 describe the use of cytisine, as compared with nicotine, for smoking cessation. Although cytisine is perceived as a novelty in the West, it has been used in daily medical practice in Poland for more than 50 years.2 In 1976, the first English-language study on the use of cytisine in Poland was published, based on the observations of 1968 patients.3 Cytisine is currently undergoing a renaissance in Poland. Two Polish studies — a cohort study conducted in 2003 through 20054 and a randomized, controlled trial conducted in 2006 through 20105 — showed . . .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom